{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:12:53Z","timestamp":1784070773638,"version":"3.55.0"},"reference-count":261,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>SARS-CoV-2, a single-stranded RNA coronavirus, causes an illness known as coronavirus disease 2019 (COVID-19). The highly transmissible virus gains entry into human cells primarily by the binding of its spike protein to the angiotensin-converting enzyme 2 receptor, which is expressed not only in lung tissue but also in cardiac myocytes and the vascular endothelium. Cardiovascular complications are frequent in patients with COVID-19 and may be a result of viral-associated systemic and cardiac inflammation or may arise from a virus-induced hypercoagulable state. This prothrombotic state is marked by endothelial dysfunction and platelet activation in both macrovasculature and microvasculature. In patients with subclinical atherosclerosis, COVID-19 may incite atherosclerotic plaque disruption and coronary thrombosis. Hypertension and obesity are common comorbidities in COVID-19 patients that may significantly raise the risk of mortality. Sedentary behaviors, poor diet, and increased use of tobacco and alcohol, associated with prolonged stay-at-home restrictions, may promote thrombosis, while depressed mood due to social isolation can exacerbate poor self-care. Telehealth interventions via smartphone applications and other technologies that document nutrition and offer exercise programs and social connections can be used to mitigate some of the potential damage to heart health.<\/jats:p>","DOI":"10.3390\/medicina57080833","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T21:27:40Z","timestamp":1629235660000},"page":"833","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cardiovascular Disease Complicating COVID-19 in the Elderly"],"prefix":"10.3390","volume":"57","author":[{"given":"Christopher","family":"Dayaramani","sequence":"first","affiliation":[{"name":"Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"De Leon","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4478-2441","authenticated-orcid":false,"given":"Allison B.","family":"Reiss","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biomedical Research Institute, NYU Long Island School of Medicine, Mineola, NY 11501, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"ref_2","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388, 1459\u20131544."},{"key":"ref_3","first-page":"e28","article-title":"Heart Disease and Stroke Statistics-2014 update","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2013.01.054","article-title":"Association between advanced age and vascular disease in different arterial territories: A population database of over 3.6 million subjects","volume":"61","author":"Savji","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Rodgers, J.L., Jones, J., Bolleddu, S.I., Vanthenapalli, S., Rodgers, L.E., Shah, K., Karia, K., and Panguluri, S.K. (2019). Cardiovascular Risks Associated with Gender and Aging. J. Cardiovasc. Dev. Dis., 6.","DOI":"10.3390\/jcdd6020019"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Neumann-Podczaska, A., Chojnicki, M., Karbowski, L.M., Al-Saad, S.R., Hashmi, A.A., Chudek, J., Tobis, S., Kropinska, S., Mozer-Lisewska, I., and Suwalska, A. (2020). Clinical characteristics and survival analysis in a small sample of older COVID-19 patients with defined 60-day outcome. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17228362"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ijcard.2020.09.048","article-title":"Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia","volume":"326","author":"Yang","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"Nadkarni","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"105250","DOI":"10.1016\/j.phrs.2020.105250","article-title":"Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions","volume":"161","author":"Awortwe","year":"2020","journal-title":"Pharmacol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"McQueenie, R., Foster, H.M.E., Jani, B.D., Katikireddi, S.V., Sattar, N., Pell, J.P., Ho, F.K., Niedzwiedz, C.L., Hastie, C.E., and Anderson, J. (2020). Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15.","DOI":"10.1101\/2020.06.10.20127563"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-S\u00e1nchez, E., Ram\u00edrez-Vargas, G., Avellaneda-L\u00f3pez, Y., Orellana-Pecino, J.I., Garc\u00eda-Mar\u00edn, E., and D\u00edaz-Jimenez, J. (2020). Eating habits and physical activity of the Spanish population during the COVID-19 pandemic period. Nutrients, 12.","DOI":"10.3390\/nu12092826"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: A review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mad.2017.05.002","article-title":"Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review","volume":"164","author":"Nolen","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Quagliariello, V., Bonelli, A., Caronna, A., Conforti, G., Iovine, M., Carbone, A., Berretta, M., Botti, G., and Maurea, N. (2020). SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers, 12.","DOI":"10.3390\/cancers12113316"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Huang, Y., Hu, Z., Hu, D., Quan, Z., Zhou, X., Fan, G., Chen, X., Liu, X., Zhang, Z., and Chen, G. (2021). Clinical characteristics, risk factors and cardiac manifestations of cancer patients with COVID-19. J. Appl. Physiol.","DOI":"10.2139\/ssrn.3783096"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clnesp.2020.10.008","article-title":"Prevalence of obesity and hypovitaminosis D in elderly with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"40","author":"Guarnieri","year":"2020","journal-title":"Clin. Nutr. ESPEN"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/s41467-021-24360-w","article-title":"Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity","volume":"12","author":"Vanderbeke","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1093\/eurheartj\/ehaa664","article-title":"Pathological features of COVID-19-associated myocardial injury: A multicentre cardiovascular pathology study","volume":"41","author":"Basso","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9059562","DOI":"10.1155\/2020\/9059562","article-title":"Association between cardiovascular burden and requirement of intensive care among patients with mild COVID-19","volume":"2020","author":"Tai","year":"2020","journal-title":"Cardiovasc. Ther."},{"key":"ref_22","first-page":"247","article-title":"Prevalence of comorbidities in COVID-19 patients: A systematic review and meta-analysis","volume":"8","author":"Baradaran","year":"2020","journal-title":"Arch. Bone Jt. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_24","first-page":"1","article-title":"Burden and prevalence of risk factors for severe COVID-19 disease in the ageing European population\u2013A SHARE-based analysis","volume":"11","author":"Ahrenfeldt","year":"2020","journal-title":"Z. Gesundh Wiss."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, Y., Gong, X., Wang, L., and Guo, J. (2020). Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: A systematic review and meta-analysis. medRxiv.","DOI":"10.1101\/2020.03.25.20043133"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.14336\/AD.2020.0502","article-title":"Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: A systematic review and meta-analysis","volume":"11","author":"Liu","year":"2020","journal-title":"Aging Dis."},{"key":"ref_28","first-page":"304","article-title":"Hypertension in patients with coronavirus disease 2019 (COVID-19): A pooled analysis","volume":"130","author":"Lippi","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/gerona\/glaa183","article-title":"Preexisting comorbidities predicting COVID-19 and mortality in the UK Biobank Community Cohort","volume":"75","author":"Atkins","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.arcmed.2020.07.003","article-title":"Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico","volume":"51","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_31","first-page":"7861","article-title":"Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy","volume":"24","author":"Geremia","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e20548","DOI":"10.2196\/20548","article-title":"At the epicenter of the American coronavirus outbreak\u2014New York inner city hospital COVID-19 experience and current data: A retrospective analysis","volume":"22","author":"Mani","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/jamainternmed.2020.3596","article-title":"Factors associated with death in critically ill patients with coronavirus disease 2019 in the US","volume":"180","author":"Gupta","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajic.2020.06.213","article-title":"Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature","volume":"49","author":"Bajgain","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e13700","DOI":"10.1111\/ijcp.13700","article-title":"Readmissions among patients with COVID-19","volume":"75","author":"Atalla","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1161\/HYPERTENSIONAHA.120.15289","article-title":"Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients","volume":"76","author":"Pan","year":"2020","journal-title":"Hypertension"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/cvr\/cvaa097","article-title":"Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: Implications for COVID-19","volume":"116","author":"Kreutz","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11906-016-0628-7","article-title":"Role of inflammation and immunity in hypertension: Recent epidemiological, laboratory, and clinical evidence","volume":"18","author":"Caillon","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11906-014-0507-z","article-title":"Inflammation and hypertension: New understandings and potential therapeutic targets","volume":"17","author":"Rudemiller","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"Strioga","year":"2011","journal-title":"Immunology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1161\/CIRCRESAHA.117.310985","article-title":"A new role of Mister (MR) T in hypertension: Mineralocorticoid receptor, immune system, and hypertension","volume":"120","author":"Barbaro","year":"2017","journal-title":"Circ. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41423-020-0454-3","article-title":"Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/HYPERTENSIONAHA.114.04147","article-title":"Oligoclonal CD8+ T cells play a critical role in the development of hypertension","volume":"64","author":"Trott","year":"2014","journal-title":"Hypertension"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: A storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm","volume":"8","author":"Tanaka","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.jhh.1001845","article-title":"Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects","volume":"19","author":"Zamora","year":"2005","journal-title":"J. Hum. Hypertens."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 Cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1073\/pnas.92.11.4862","article-title":"Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice","volume":"92","author":"Hirota","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: From cardiac protection to cardiac failure","volume":"74","author":"Fontes","year":"2015","journal-title":"Cytokine"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3159283","DOI":"10.1155\/2019\/3159283","article-title":"Arterial hypertension and interleukins: Potential therapeutic target or future diagnostic marker?","volume":"2019","author":"Tanase","year":"2019","journal-title":"Int. J. Hypertens."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e13629","DOI":"10.1111\/eci.13629","article-title":"Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience","volume":"51","author":"Ruscica","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1038\/s41598-020-70387-2","article-title":"Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019","volume":"10","author":"Liu","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: A meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4269\/ajtmh.21-0165","article-title":"High mobility group box 1 and interleukin 6 at intensive care unit admission as biomarkers in critically ill COVID-19 Patients","volume":"105","author":"Sivakorn","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5582\/ddt.2020.03006","article-title":"Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?","volume":"14","author":"Zhang","year":"2020","journal-title":"Drug Discov. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40121-020-00326-1","article-title":"Interleukin-6 blocking vs. JAK-STAT inhibition for prevention of lung injury in patients with COVID-19","volume":"9","author":"Meletiadis","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jmv.26429","article-title":"Late onset infectious complications and safety of tocilizumab in the management of COVID-19","volume":"93","author":"Pettit","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e001089","DOI":"10.1136\/jitc-2020-001089","article-title":"Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy","volume":"8","author":"Montesarchio","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00408-021-00451-9","article-title":"Tocilizumab in Hospitalized Patients with COVID-19: A Meta Analysis of Randomized Controlled Trials","volume":"199","author":"Selvaraj","year":"2021","journal-title":"Lung"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"EMAP-CAP Investigators, Gordon, A.C., Mouncey, P.R., Al-Beidh, F., Rowan, K.M., Nichol, A.D., Arabi, Y.M., Annane, D., Beane, A., and van Bentum-Puijk, W. (2021). Interleukin-6 Receptor Antagonists in Critically Ill Patients with COVID-19. N. Engl. J. Med., 384, 1491\u20131502.","DOI":"10.1056\/NEJMoa2100433"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"102563","DOI":"10.1016\/j.autrev.2020.102563","article-title":"Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection","volume":"19","author":"Cunningham","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"102560","DOI":"10.1016\/j.autrev.2020.102560","article-title":"Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: An update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1165\/rcmb.2002-0120OC","article-title":"Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice","volume":"29","author":"Pascaud","year":"2003","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"Tu","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/ATVBAHA.111.242719","article-title":"Biphasic time course of the changes in aldosterone biosynthesis under high-salt conditions in Dahl salt-sensitive rats","volume":"32","author":"Morizane","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajh\/hpz009","article-title":"Molecular and cellular effect of angiotensin 1-7 on hypertensive kidney disease","volume":"32","author":"Chen","year":"2019","journal-title":"Am. J. Hypertens."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An MRNA vaccine against SARS-CoV-2\u2014Preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1080\/07391102.2020.1754293","article-title":"A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin","volume":"39","author":"Hasan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus Disease 2019 (COVID-19): Do angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers have a biphasic effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102907","DOI":"10.1016\/j.ebiom.2020.102907","article-title":"SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy","volume":"58","author":"Chung","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fcvm.2020.00138","article-title":"Renin-angiotensin-aldosterone system blockers are not associated with coronavirus disease 2019 (COVID-19) hospitalization: Study of 1439 UK Biobank cases","volume":"7","author":"McCracken","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"23436","DOI":"10.18632\/aging.104019","article-title":"Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19","volume":"12","author":"Cheng","year":"2020","journal-title":"Aging"},{"key":"ref_81","first-page":"1769","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: What is the evidence?","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e085","DOI":"10.1097\/j.pbj.0000000000000085","article-title":"Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: A systematic review","volume":"5","author":"Nunes","year":"2020","journal-title":"Porto Biomed. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jjcc.2020.10.015","article-title":"Lack of association of antihypertensive drugs with the risk and severity of COVID-19: A meta-analysis","volume":"77","author":"Ren","year":"2021","journal-title":"J. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e021154","DOI":"10.1161\/JAHA.120.021154","article-title":"Renin-Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID-19","volume":"10","author":"Loader","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Jia, N., Zhang, G., Sun, X., Wang, Y., Zhao, S., Chi, W., Dong, S., Xia, J., Zeng, P., and Liu, D. (2021). Influence of angiotensin converting enzyme inhibitors\/angiotensin receptor blockers on the risk of all-cause mortality and other clinical outcomes in patients with confirmed COVID-19: A systemic review and meta-analysis. J. Clin. Hypertens.","DOI":"10.1111\/jch.14329"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e001353","DOI":"10.1136\/openhrt-2020-001353","article-title":"Renin-angiotensin-aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: Systematic review and meta-analysis","volume":"7","author":"Ssentongo","year":"2020","journal-title":"Open Heart"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.120.16314","article-title":"Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients","volume":"77","author":"Semenzato","year":"2021","journal-title":"Hypertension"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1093\/infdis\/jiaa447","article-title":"Continued in-hospital ACE inhibitor and ARB use in hypertensive COVID-19 patients is associated with positive clinical outcomes","volume":"222","author":"Lam","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Gemmati, D., and Tisato, V. (2020). Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19. Genes, 11.","DOI":"10.3390\/genes11091044"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2217\/pgs-2020-0048","article-title":"ACE2 and COVID-19: Using antihypertensive medications and pharmacogenetic considerations","volume":"21","author":"Snyder","year":"2020","journal-title":"Pharmacogenomics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2459\/JCM.0000000000001160","article-title":"Therapy with RAS inhibitors during the COVID-19 pandemic","volume":"22","author":"Spaccarotella","year":"2021","journal-title":"J. Cardiovasc. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/14779072.2020.1814143","article-title":"COVID-19 and renin-angiotensin system modulators: What do we know so far?","volume":"18","author":"Ashraf","year":"2020","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_93","first-page":"274","article-title":"Considerations on the use of antihypertensive blockers of the renin-angiotensin system in adults and children in the face of the COVID-19 pandemic","volume":"77","year":"2020","journal-title":"Bol. Med. Hosp. Infant Mex."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","article-title":"Definitions and diagnosis of pulmonary hypertension","volume":"62","author":"Hoeper","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1513\/AnnalsATS.202005-521OC","article-title":"A Survey-based Estimate of COVID-19 Incidence and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension and impact on the process of care","volume":"17","author":"Lee","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Ryan, J.J., Melendres-Groves, L., Zamanian, R.T., Oudiz, R.J., Chakinala, M., Rosenzweig, E.B., and Gomberg-Maitland, M. (2020). Care of patients with pulmonary arterial hypertension during the coronavirus (COVID-19) pandemic. Pulm. Circ., 10.","DOI":"10.1177\/2045894020920153"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/heartjnl-2020-317355","article-title":"Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19","volume":"106","author":"Pagnesi","year":"2020","journal-title":"Heart"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1513\/AnnalsATS.202008-1014ED","article-title":"COVID-19 and pulmonary arterial hypertension: Early data and many questions","volume":"17","author":"Farha","year":"2020","journal-title":"Ann. Am. Thorac Soc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1164\/rccm.201712-2570OC","article-title":"AMP-activated protein kinase phosphorylation of angiotensin-converting enzyme 2 in endothelium mitigates pulmonary hypertension","volume":"198","author":"Zhang","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1164\/rccm.202005-1906ED","article-title":"Home nitric oxide therapy for COVID-19","volume":"202","author":"Alvarez","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.niox.2020.07.003","article-title":"Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19","volume":"103","author":"Adusumilli","year":"2020","journal-title":"Nitric Oxide"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"S1767","DOI":"10.21037\/jtd.2019.09.14","article-title":"Pharmacotherapy for pulmonary arterial hypertension","volume":"11","author":"Parikh","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000350395","article-title":"Endothelin-1 downregulates angiotensin-converting enzyme-2 expression in human bronchial epithelial cells","volume":"91","author":"Zhang","year":"2013","journal-title":"Pharmacology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.0306-5251.2001.01422.x","article-title":"Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man","volume":"52","author":"Wenzel","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.healun.2020.04.007","article-title":"Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?","volume":"39","author":"Badagliacca","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"114057","DOI":"10.1016\/j.bcp.2020.114057","article-title":"Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost","volume":"178","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1021\/acs.jproteome.0c00365","article-title":"Serum proteomics in COVID-19 patients: Altered coagulation and complement status as a function of IL-6 level","volume":"19","author":"Thomas","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Why the immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia are distinct from macrophage activation syndrome with disseminated intravascular coagulation","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheum."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"A Hematological findings and complications of COVID-19","volume":"95","author":"Terpos","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/phar.2465","article-title":"Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID-19","volume":"40","author":"Dobesh","year":"2020","journal-title":"Pharmacotherapy"},{"key":"ref_112","first-page":"100692","article-title":"A review of venous thromboembolism phenomena in COVID-19 patients","volume":"46","author":"Ghahramani","year":"2020","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3389\/fmed.2020.00557","article-title":"Pulmonary thrombosis or embolism in a large cohort of hospitalized patients with COVID-19","volume":"7","author":"Benito","year":"2020","journal-title":"Front. Med."},{"key":"ref_114","first-page":"9161","article-title":"Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: Clinical implications","volume":"24","author":"Voicu","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Chen, J., Wang, X., Zhang, S., Lin, B., Wu, X., Wang, Y., Wang, X., Yang, M., Sun, J., and Xie, Y. (2020). Characteristics of acute pulmonary embolism in patients with COVID-19 associated pneumonia from the city of Wuhan. Clin. Appl. Thromb. Hemost., 26.","DOI":"10.1177\/1076029620936772"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1538-7836.2003.00089.x","article-title":"The participation of leukocytes in coagulant reactions","volume":"1","author":"Bouchard","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11239-020-02172-x","article-title":"Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19","volume":"50","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit. Care Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cyto.2018.01.007","article-title":"Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1beta, IL-6 and IL-8","volume":"110","author":"Bester","year":"2018","journal-title":"Cytokine"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1080\/09537104.2020.1810224","article-title":"A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: Naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients","volume":"31","author":"Roncati","year":"2020","journal-title":"Platelets"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/jth.14859","article-title":"D-dimer levels on admission to predict in-hospital mortality in patients with COVID-19","volume":"18","author":"Zhang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trsl.2020.05.006","article-title":"Microvascular thrombosis: Experimental and clinical implications","volume":"225","author":"Bray","year":"2020","journal-title":"Transl. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2020.08.039","article-title":"COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?","volume":"196","author":"Vianello","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.15420\/ecr.2020.22","article-title":"Myocardial and microvascular injury due to coronavirus disease 2019","volume":"15","author":"Montone","year":"2020","journal-title":"Eur. Cardiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/jth.14872","article-title":"Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19","volume":"18","author":"Whyte","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"Connors","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1017\/S0950268820002022","article-title":"D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: A meta-analysis","volume":"148","author":"Simadibrata","year":"2020","journal-title":"Epidemiol. Infect."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2020.04.021","article-title":"Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients","volume":"190","author":"Roncon","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1056\/NEJMc2009787","article-title":"Large-vessel stroke as a presenting feature of COVID-19 in the young","volume":"382","author":"Oxley","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11239-020-02176-7","article-title":"Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients","volume":"50","author":"Cantador","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.recesp.2020.05.013","article-title":"Arterial thrombotic complications in hospitalized patients with COVID-19","volume":"73","author":"Rey","year":"2020","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s12975-020-00818-9","article-title":"COVID-19-related stroke","volume":"11","author":"Hess","year":"2020","journal-title":"Transl. Stroke Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3121\/cmr.2009.866","article-title":"Virchow\u2019s contribution to the understanding of thrombosis and cellular biology","volume":"8","author":"Kumar","year":"2010","journal-title":"Clin. Med. Res."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1186\/s13063-021-05361-y","article-title":"A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial","volume":"22","author":"Sharma","year":"2021","journal-title":"Trials"},{"key":"ref_140","first-page":"e72","article-title":"The prevalence of underlying diseases and comorbidities in COVID-19 patients; an updated systematic review and meta-analysis","volume":"8","author":"Khateri","year":"2020","journal-title":"Arch. Acad. Emerg. Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complication in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1152\/physrev.00035.2020","article-title":"Inflammation and thrombosis in COVID-19 pathophysiology: Proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets","volume":"101","author":"Sriram","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJMra1808137","article-title":"Acute infection and myocardial infarction","volume":"380","author":"Musher","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4070\/kcj.2020.0205","article-title":"Updates of cardiovascular manifestations in COVID-19: Korean experience to broaden worldwide perspectives","volume":"50","author":"Kim","year":"2020","journal-title":"Korean Circ. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.18433\/jpps31501","article-title":"Assessing the elevation of cardiac biomarkers and the severity of COVID-19 infection: A meta-analysis","volume":"23","author":"Walker","year":"2020","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.3346\/jkms.2020.35.e349","article-title":"The implication of cardiac injury score on in-hospital mortality of coronavirus disease 2019","volume":"35","author":"Kim","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"678","DOI":"10.21037\/cdt-20-510","article-title":"Analysis of influencing factors related to elevated serum troponin I level for COVID-19 patients in Yichang, China","volume":"10","author":"Fan","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang","year":"2020","journal-title":"Biomark. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s13054-020-03183-z","article-title":"Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: A meta-analysis and systematic review","volume":"24","author":"Li","year":"2020","journal-title":"Crit. Care"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.ajem.2020.05.073","article-title":"Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis","volume":"38","author":"Henry","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_151","first-page":"227","article-title":"Risk factors and laboratory test results associated with severe illness and mortality in COVID-19 patients: A systematic review","volume":"52","author":"Setiati","year":"2020","journal-title":"Acta. Med. Indones."},{"key":"ref_152","first-page":"191","article-title":"Evaluation of organ function in patients with severe COVID-19 infections","volume":"155","author":"Zhu","year":"2020","journal-title":"Med. Clin. (Engl. Ed.)"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"16384","DOI":"10.1038\/s41598-020-73136-7","article-title":"Analysis of the clinical characteristics of 77 COVID-19 deaths","volume":"10","author":"Wang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1002\/ehf2.13022","article-title":"Risk factors for myocardial injury in patients with coronavirus disease 2019 in China","volume":"7","author":"Fan","year":"2020","journal-title":"ESC Heart Fail."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMc2009020","article-title":"ST-Segment elevation in patients with COVID-19\u2014A case series","volume":"382","author":"Bangalore","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Special article\u2014Acute myocardial injury in patients hospitalized with COVID-19 infection: A review","volume":"63","author":"Bavishi","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1161\/CIRCULATIONAHA.120.047349","article-title":"Description and proposed management of the acute COVID-19 cardiovascular syndrome","volume":"9","author":"Hendren","year":"2020","journal-title":"Circulation"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jocs.15164","article-title":"Myocardial injury in severe and critical coronavirus disease 2019 patients","volume":"36","author":"Guo","year":"2020","journal-title":"J. Card. Surg."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.21037\/cdt-20-535","article-title":"Incidence of myocardial injury in coronavirus disease 2019 (COVID-19): A pooled analysis of 7,679 patients from 53 studies","volume":"10","author":"Gu","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_161","first-page":"985","article-title":"Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak","volume":"73","author":"Zamorano","year":"2020","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis","volume":"298","author":"Suh","year":"2020","journal-title":"Radiology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.thromres.2020.04.024","article-title":"Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy","volume":"191","author":"Lodigiani","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_165","first-page":"e10708","article-title":"COVID-19 infection complicated by a complete occlusion of the left circumflex artery with acute restenosis after drug-eluting stent placement","volume":"12","author":"Zaher","year":"2020","journal-title":"Cureus"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"757","DOI":"10.21470\/1678-9741-2020-0303","article-title":"COVID-19\u2014Endothelial axis and coronary artery bypass graft patency: A target for therapeutic intervention?","volume":"35","author":"Topal","year":"2020","journal-title":"Braz. J. Cardiovasc. Surg."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1161\/CIRCULATIONAHA.117.030578","article-title":"Prognostic value of coronary artery calcium in the PROMISE study (prospective multicenter imaging study for evaluation of chest pain)","volume":"136","author":"Budoff","year":"2017","journal-title":"Circulation"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/j.jcmg.2020.07.004","article-title":"COVID Research Group of Lariboisiere Hospital. Coronary artery calcification and complications in patients with COVID-19","volume":"13","author":"Dillinger","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/ehjci\/jeaa202","article-title":"Subclinical coronary artery disease in COVID-19 patients","volume":"21","author":"Fovino","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_171","first-page":"e927674","article-title":"Retrospective study of clinical features of COVID-19 in inpatients and their association with disease severity","volume":"26","author":"Wang","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"e041295","DOI":"10.1136\/bmjopen-2020-041295","article-title":"Association between biomarkers and COVID-19 severity and mortality: A nationwide Danish cohort study","volume":"10","author":"Hodges","year":"2020","journal-title":"BMJ Open"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A test in context: High-sensitivity c-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajem.2020.08.076","article-title":"Early predictors of mortality for moderate to severely ill patients with COVID-19","volume":"45","author":"Aksel","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ajh.2011.241","article-title":"Increased serum ferritin predicts the development of hypertension among middle-aged men","volume":"25","author":"Kim","year":"2012","journal-title":"Am. J. Hypertens."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Liang, M., He, M., Tang, J., He, X., Liu, Z., Feng, S., Chen, P., Li, H., Xue, Y., and Bai, T. (2020). Novel risk scoring system for predicting acute respiratory distress syndrome among hospitalized patients with coronavirus disease 2019 in Wuhan, China. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05561-y"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Lourens, P.J., Steenkamp, J., Kell, D.B., and Pretorius, E. (2020). Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218234"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Lee, J., Park, H.K., Kwon, M.J., Ham, S.Y., Kim, J.M., Lim, S.Y., and Song, J.U. (2020). Decreased lung function is associated with elevated ferritin but not iron or transferrin saturation in 42,927 healthy Korean men: A cross-sectional study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231057"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12026-020-09145-5","article-title":"COVID-19 as part of the hyperferritinemic syndromes: The role of iron depletion therapy","volume":"68","author":"Perricone","year":"2020","journal-title":"Immunol. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"111228","DOI":"10.1016\/j.biopha.2021.111228","article-title":"The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators","volume":"136","author":"Habib","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jamacardio.2020.1105","article-title":"Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality","volume":"5","author":"Bonow","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"Madjid","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","article-title":"Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets","volume":"26","author":"Ramji","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ. Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1172\/JCI67526","article-title":"Collagenases and cracks in the plaque","volume":"123","author":"Libby","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s42979-020-00290-0","article-title":"A smartphone enabled approach to manage COVID-19 lockdown and economic crisis","volume":"1","author":"Maghdid","year":"2020","journal-title":"SN Comput. Sci."},{"key":"ref_188","first-page":"1","article-title":"Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak","volume":"27","author":"Freedman","year":"2020","journal-title":"J. Travel Med."},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Naser, A.Y., Al-Hadithi, H.T., Dahmash, E.Z., Alwafi, H., Alwan, S.S., and Abdullah, Z.A. (2020). The effect of the 2019 coronavirus disease outbreak on social relationships: A cross-sectional study in Jordan. Int. J. Soc. Psychiatry.","DOI":"10.1177\/0020764020966631"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(20)30460-8","article-title":"The psychological impact of quarantine and how to reduce it: Rapid review of the evidence","volume":"395","author":"Brooks","year":"2020","journal-title":"Lancet"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e924609","DOI":"10.12659\/MSM.924609","article-title":"comparison of prevalence and associated factors of anxiety and depression among people affected by versus people unaffected by quarantine during the COVID-19 epidemic in southwestern China","volume":"26","author":"Lei","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Lei, H., Wu, X., Wang, X., Xu, M., Xie, Y., Du, X., Cowling, B.J., Li, Y., and Shu, Y. (2020). Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation\/quarantine and social distancing against COVID-19 in China. Clin. Infect. Dis.","DOI":"10.1093\/cid\/ciaa1584"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"575091","DOI":"10.3389\/fpubh.2020.575091","article-title":"Behavioral change towards reduced intensity physical activity is disproportionately prevalent among adults with serious health issues or self-perception of high risk during the UK COVID-19 lockdown","volume":"8","author":"Rogers","year":"2020","journal-title":"Front. Public Health"},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Bourdas, D.I., and Zacharakis, E.D. (2020). Impact of COVID-19 lockdown on physical activity in a sample of Greek adults. Sports, 8.","DOI":"10.3390\/sports8100139"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1007.030703","article-title":"SARS control and psychological effects of quarantine, Toronto, Canada","volume":"10","author":"Hawryluck","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1249\/MSS.0b013e3181c3aa7e","article-title":"Sedentary behaviors increase risk of cardiovascular disease mortality in men","volume":"42","author":"Warren","year":"2010","journal-title":"Med. Sci. Sports. Exerc."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1016\/j.jacc.2013.03.031","article-title":"Relationship of sedentary behavior and physical activity to incident cardiovascular disease","volume":"61","author":"Chomistek","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Arena, R., Bond, S., Calvo, I.R., Lebowicz, L., Ozemek, C., Severin, R., Laddu, D., Faghy, M.A., Lavie, C.J., and Carbone, S. (2021). Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era. Prog. Cardiovasc. Dis.","DOI":"10.1016\/j.pcad.2021.06.008"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1177\/2047487317721021","article-title":"Impact of persistence and non-persistence in leisure time physical activity on coronary heart disease and all-cause mortality: The Copenhagen City Heart Study","volume":"24","author":"Schnohr","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2015.10.044","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis","volume":"67","author":"Anderson","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1161\/01.CIR.102.12.1351","article-title":"Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men","volume":"102","author":"DeSouza","year":"2000","journal-title":"Circulation"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5114\/aoms.2012.31614","article-title":"Impact of physical activity on inflammation: Effects on cardiovascular disease risk and other inflammatory conditions","volume":"8","author":"Ertek","year":"2012","journal-title":"Arch. Med. Sci."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1161\/01.CIR.0000109141.48980.37","article-title":"Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis","volume":"109","author":"Laufs","year":"2004","journal-title":"Circulation"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ijpvm.IJPVM_209_16","article-title":"Effects of different modes of exercise training on body composition and risk factors for cardiovascular disease in middle-aged men","volume":"9","author":"Mohammadi","year":"2018","journal-title":"Int. J. Prev. Med."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10654-006-9100-3","article-title":"Associations between overall physical activity level and cardiovascular risk factors in an adult population","volume":"22","author":"Aadahl","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5551\/jat.42937","article-title":"Response of lipids and lipoproteins to regular aquatic endurance exercise: A meta-analysis of randomized controlled trials","volume":"2","author":"Igarashi","year":"2019","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Ogura, A., Izawa, K.P., Tawa, H., Kureha, F., Wada, M., Harada, N., Ikeda, Y., Kimura, K., Kondo, N., and Kanai, M. (2021). Older phase 2 cardiac rehabilitation patients engaged in gardening maintained physical function during the COVID-19 pandemic. Heart Vessels.","DOI":"10.1007\/s00380-021-01892-1"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pcad.2020.03.009","article-title":"Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: Special focus in older people","volume":"63","author":"Lavie","year":"2020","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_209","first-page":"20","article-title":"Physical activity during COVID-19 induced lockdown: Recommendations","volume":"15","author":"Groneberg","year":"2020","journal-title":"J. Occup. Med. Toxicol."},{"key":"ref_210","first-page":"1","article-title":"Associations of sedentary behaviors and incidence of unhealthy diet during the COVID-19 quarantine in Brazil","volume":"24","author":"Werneck","year":"2020","journal-title":"Public Health Nutr."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Maricarmen, V., Buman, M., DesRoches, T., and Wharton, C. (2020). From TVs to tablets: The relation between device-specific screen time and health-related behaviors and characteristics. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09410-0"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.orcp.2020.05.004","article-title":"Self-quarantine and weight gain related risk factors during the COVID-19 pandemic","volume":"14","author":"Zachary","year":"2020","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"105002","DOI":"10.1016\/j.appet.2020.105002","article-title":"Eating behavior and food purchases during the COVID-19 lockdown: A cross-sectional study among adults in the Netherlands","volume":"157","author":"Poelman","year":"2020","journal-title":"Appetite"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/oby.22850","article-title":"Weight stigma and the \u201cQuarantine-15\u201d","volume":"28","author":"Pearl","year":"2020","journal-title":"Obesity"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-020-02399-5","article-title":"Eating habits and lifestyle changes during COVID-19 lockdown: An Italian survey","volume":"18","author":"Gualtieri","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41367-020-0018-0","article-title":"What is the best diet for cardiovascular wellness? A comparison of different nutritional models","volume":"10","author":"Migliaccio","year":"2020","journal-title":"Int. J. Obes. Suppl."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: A systematic analysis for the Global Burden of Disease Study 2013","volume":"385","author":"Abubakar","year":"2015","journal-title":"Lancet"},{"key":"ref_218","first-page":"1950","article-title":"Dietary fruits and vegetables and cardiovascular diseases risk","volume":"57","author":"Alissa","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/dyw319","article-title":"Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies","volume":"46","author":"Aune","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.numecd.2020.05.020","article-title":"Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease","volume":"30","author":"Mattioli","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_221","first-page":"3898","article-title":"Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund\/American Institute for Cancer Research (WCRF\/AICR) recommendations: From hyper-inflammation to cardiac dysfunctions","volume":"25","author":"Quagliariello","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","unstructured":"Ruscica, M., Penson, P.E., Ferri, N., Sirtori, C.R., Pirro, M., Mancini, G., Sattar, N., Toth, P.P., Sahebkar, A., and Lavie, C.J. (2021). Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases\u2014A position paper from the International Lipid Expert Panel (ILEP). Prog. Cardiovasc. Dis.","DOI":"10.1016\/j.pcad.2021.06.010"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Sidor, A., and Rzymski, P. (2020). Dietary choices and habits during COVID-19 lockdown: Experience from Poland. Nutrients, 12.","DOI":"10.3390\/nu12061657"},{"key":"ref_224","first-page":"1","article-title":"The effect of anxiety levels of elderly people in quarantine on depression during COVID-19 pandemic","volume":"7","author":"Yildirim","year":"2021","journal-title":"Soc. Work Public Health"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"563417","DOI":"10.3389\/fpsyt.2021.563417","article-title":"Coping With COVID-19: Mindfulness-Based Approaches for Mitigating Mental Health Crisis","volume":"12","author":"Antonova","year":"2021","journal-title":"Front Psychiatry"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/wps.20758","article-title":"Anxiety and depression among general population in China at the peak of the COVID-19 epidemic","volume":"19","author":"Li","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Lu, H., Nie, P., and Qian, L. (2020). Do quarantine experiences and attitudes towards COVID-19 affect the distribution of mental health in China? A quantile regression analysis. Appl. Res. Qual. Life, 1\u201318.","DOI":"10.1007\/s11482-020-09851-0"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/13811118.2020.1830242","article-title":"Suicide in the time of COVID-19: Review and recommendations","volume":"24","author":"Zalsman","year":"2020","journal-title":"Arch. Suicide Res."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2217\/fca-2020-0055","article-title":"COVID-19 outbreak: Impact of the quarantine-induced stress on cardiovascular disease risk","volume":"16","author":"Mattioli","year":"2020","journal-title":"Future Cardiol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.23736\/S2724-5683.20.05309-8","article-title":"What about heart and mind in the COVID-19 era?","volume":"69","author":"Mazza","year":"2021","journal-title":"Minerva Cardiol. Angiol."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Monaghesh, E., and Hajizadeh, A. (2020). The role of telehealth during COVID-19 outbreak: A systematic review based on current evidence. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09301-4"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Reiss, A.B., De Leon, J., Dapkins, I.P., Shahin, G., Peltier, R., and Goldberg, E.R. (2020). A telemedicine approach to COVID-19 assessment and triage. Medicina, 56.","DOI":"10.3390\/medicina56090461"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2307\/249008","article-title":"Perceived usefulness, perceived ease of use, and user acceptance of information technology","volume":"13","author":"Davis","year":"1989","journal-title":"MIS Quart."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1057\/sth.2013.10","article-title":"The digitally engaged patient: Self-monitoring and self-care in the digital health era","volume":"11","author":"Lupton","year":"2013","journal-title":"Soc. Theory Health"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/1357633X16674087","article-title":"Evaluating barriers to adopting telemedicine worldwide: A systematic review","volume":"24","author":"Karem","year":"2018","journal-title":"J. Telemed. Telecare"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2016.07.029","article-title":"Improving hypertension control and patient engagement using digital tools","volume":"130","author":"Milani","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.120.15873","article-title":"Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: An international expert position paper","volume":"76","author":"Omboni","year":"2020","journal-title":"Hypertension"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1071\/PY17187","article-title":"Effects of home telemonitoring on the control of high blood pressure: A randomised control trial in the Fangzhuang Community Health Center, Beijing","volume":"24","author":"Pan","year":"2018","journal-title":"Aust. J. Prim. Health"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/tmj.2011.0158","article-title":"Telemedicine for the reduction of myocardial infarction mortality: A systematic review and a meta-analysis of published studies","volume":"18","author":"Cadeddu","year":"2012","journal-title":"Telemed. e-Health"},{"key":"ref_240","first-page":"A10190570","article-title":"Evaluation of telemedicine in patients suspected of acute coronary syndrome at a non-invasive centre","volume":"67","author":"Mahmoud","year":"2020","journal-title":"Dan. Med. J."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","volume":"5","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.xcrm.2020.100052","article-title":"Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection","volume":"1","author":"Sharma","year":"2020","journal-title":"Cell. Rep. Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Samidurai, A., and Das, A. (2020). Cardiovascular complications associated with COVID-19 and potential therapeutic strategies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186790"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1042\/CS20210182","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: Potential allies in the COVID-19 pandemic instead of a threat?","volume":"135","author":"Simko","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(21)00214-9","article-title":"Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): A prospective, parallel group, randomised, controlled, open-label trial","volume":"9","author":"Bauer","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and diabetes mellitus: From pathophysiology to clinical management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/07853890.2020.1836566","article-title":"Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: Data from the Spanish SEMI-COVID-19 Registry","volume":"53","author":"Buonaiuto","year":"2021","journal-title":"Ann. Med."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.immuni.2021.07.017","article-title":"Accelerated COVID-19 vaccine development: Milestones, lessons, and prospects","volume":"54","author":"Bok","year":"2021","journal-title":"Immunity"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"100102","DOI":"10.1016\/j.metop.2021.100102","article-title":"Major cardiac concerns in therapy and vaccinations for COVID-19","volume":"11","author":"Junapudi","year":"2021","journal-title":"Metab. Open"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"213","DOI":"10.36660\/abc.20210012","article-title":"Vaccinating patients with heart disease against COVID-19: The reasons for priority","volume":"16","author":"Martins","year":"2021","journal-title":"Arq. Bras. Cardiol."},{"key":"ref_252","doi-asserted-by":"crossref","unstructured":"Watanabe, M., Balena, A., Tuccinardi, D., Tozzi, R., Risi, R., Masi, D., Caputi, A., Rossetti, R., Spoltore, M.E., and Filippi, V. (2021). Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine. Diabetes Metab. Res. Rev., e3465.","DOI":"10.1101\/2021.04.13.21255402"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices\u2014United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clinimag.2021.06.019","article-title":"Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: A report of two cases","volume":"78","author":"Mansour","year":"2021","journal-title":"Clin. Imaging"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Crespo-Leiro, M.G., Barge-Caballero, E., and Gustafsson, F. (2021). Efficacy of the COVID-19 vaccine in heart transplant recipients: What we know and what we ignore. Eur. J. Heart Fail.","DOI":"10.1002\/ejhf.2302"},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Hall, V.G., Ferreira, V.H., Ierullo, M., Ku, T., Marinelli, T., Majchrzak-Kita, B., Yousuf, A., Kulasingam, V., Humar, A., and Kumar, D. (2021). Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients. Am. J. Transplant.","DOI":"10.1111\/ajt.16766"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/d41586-021-01696-3","article-title":"Delta coronavirus variant: Scientists brace for impact","volume":"595","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"e2020368118","DOI":"10.1073\/pnas.2020368118","article-title":"Vaccinology in the post-COVID-19 era","volume":"118","author":"Rappuoli","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"102287","DOI":"10.1016\/j.ijinfomgt.2020.102287","article-title":"Information technology solutions, challenges, and suggestions for tackling the COVID-19 pandemic","volume":"57","author":"He","year":"2020","journal-title":"Int. J. Inf. Manag."},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Stohr, J., Zwart, V.F., Goderski, G., Meijer, A., Nagel-Imming, C., Kluytmans-van den Bergh, M., Pas, S.D., van den Oetelaar, F., Hellwich, M., and Gan, K.H. (2021). Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community. Clin. Microbiol. Infect.","DOI":"10.1101\/2021.02.21.21252153"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/833\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:45:59Z","timestamp":1760165159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/8\/833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":261,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["medicina57080833"],"URL":"https:\/\/doi.org\/10.3390\/medicina57080833","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,17]]}}}